#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovial sarcoma recurrent Ovarian cancer stage IV Bulbospinal muscular atrophy congenital Malignant peritoneal neoplasm VEXAS syndrome Fibrous dysplasia of bone Proteus syndrome Factor VIII deficiency Infantile apnoea Spinal cord injury cervical Antiphospholipid antibodies Ewing's sarcoma metastatic Non-small cell lung cancer metastatic Fallopian tube cancer Immune-mediated enterocolitis More trials…

    Learn about Rare Diseases

    Krabbe’s disease – Treatment Nephrotic syndrome – Life with Disease Small intestine leiomyosarcoma – Basic Information Pleomorphic leiomyosarcoma Mast cell activation syndrome – Trials in Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Idiopathic pulmonary fibrosis Congenital hypotransferrinaemia – Treatment Adrenogenital syndrome – Life with Disease Mucous membrane pemphigoid – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tivozanib Eptacog Beta (Activated) Elasomeran Ep262 Lurbinectedin Human Coagulation Factor Ix Setmelanotide Hydroxypropyl Cellulose Lf Censavudine Teicoplanin Gen1055 Aluminium Oxide Rezafungin Acetate Tasimelteon Rifaximin Omp64 Vx-670 Deutivacaftor Dexamethasone Acetate Ph. Eur. Pemetrexed Disodium More therapies…

    Learn about Your Condition

    Sickle cell anaemia Mantle cell lymphoma stage III Endocarditis enterococcal Renal failure Rectal neoplasm Neuroendocrine carcinoma Tumour thrombosis Thymoma malignant Hereditary ataxia Encephalitis autoimmune Frontotemporal dementia Acute lymphocytic leukaemia Partial lipodystrophy Mitral valve incompetence Cancer fatigue More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of BI 1810631 (C‑14) oral solution, BI 1810631 (C‑14) IV microtracer, and BI 1810631 tablet to assess absorption and metabolism in healthy men

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Zongertinib
    The Netherlands

  • Safety and Tolerability of Topical Iodine (DLQ03) in Patients with Mild to Moderate Atopic Dermatitis Colonized with Staphylococcus aureus

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    The Netherlands

  • Efficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    • Dexamethasone
    • Dexamethasone Ph. Eur.
    Belgium Bulgaria France Germany Greece Hungary +4

  • A study to compare the safety of ketamine hydrochloride and esketamine in healthy men for the treatment of depression

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Esketamine Hydrochloride
    Germany

  • A study to compare the absorption of apixaban capsules and apixaban tablets in healthy volunteers to prevent thrombosis.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Thrombosis
    Investigated Drugs:
    • Apixaban
    Spain

  • Phase 3 Study of Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Metastatic NSCLC with PD-L1 TPS ≥50%

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    Germany Poland Romania Spain
Previous Page
1 … 925 926 927 928 929 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!